Erica Gregonis, MD
Pulmonary Disease · Richmond, KYNPI 1326242991
Payments from drug & device makers
Across 524 payments — averaging $743.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$382K
- Viiv Healthcare Company$3K
- Intuitive Surgical$754
- AstraZeneca$514
- Grifols USA, LLC$390
- Verona Pharma, Inc.$330
- plus $2K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 363 | $382,303 |
| Viiv Healthcare Company | 2 | $3,493 |
| Intuitive Surgical | 3 | $754 |
| AstraZeneca | 31 | $514 |
| Grifols USA, LLC | 29 | $390 |
| Verona Pharma, Inc. | 9 | $330 |
| Boehringer Ingelheim | 14 | $300 |
| Pulmonx Corporation | 2 | $201 |
| Sanofi | 8 | $177 |
| Insmed, Inc. | 8 | $161 |
| Philips North America LLC | 8 | $138 |
| Genentech USA, Inc. | 6 | $123 |
| Amgen | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| Mallinckrodt Enterprises LLC | 3 | $67 |
| Actelion Pharmaceuticals US, Inc. | 3 | $65 |
| Mylan Specialty L.p. | 3 | $44 |
| Mallinckrodt Hospital Products Inc. | 2 | $42 |
| AbbVie | 2 | $41 |
| United Therapeutics Corporation | 2 | $40 |
| Circassia Inc. | 2 | $36 |
| Novartis | 2 | $27 |
| Breathe Technologies, Inc. | 1 | $25 |
| Baxter Healthcare | 1 | $23 |
| Viatris Specialty LLC | 1 | $21 |
| Merck | 1 | $19 |
| Inogen, Inc. | 3 | $18 |
| Fisher & Paykel Healthcare Inc | 1 | $14 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$389,657 in reported general payments places this provider in the 95th percentile of 226 pulmonary disease providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Richmond
- John McConnellLouisville$3.5M
- Girish NairLexington$852K
- Sally SulimanLouisville$472K
- Mohamed SaadLouisville$440K
- David WinslowLouisville$431K
- Firas KouraGeorgetown$423K
- Karim El-KershLouisville$379K
- Harold HallerLouisville$369K
- Steven KoenigMorehead$242K
- Samantha BaahLouisville$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.